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ABSTRACT
Photothermal therapy (PTT) is a nanotechnology-assisted cancer hyperthermia approach in which the
interaction between laser light and plasmonic nanoparticles (NPs) generates localized heating. The
exploitation of plasmonic NPs in association with active targeting moieties causes the preferential accu-
mulation of NPs inside cancer cells, thereby providing targeted PTT. Herein, we evaluate the effect of
folic acid (FA) as an active targeting agent in enhancing the photothermal efficiency of multifunctional
Iron (III) Oxide (Fe2O3)@Au core- shell NPs. Fe2O3@Au NPs were synthesized, modified with FA and then
characterized. Human nasopharyngeal (KB) cancer cells were treated with different concentrations of
Fe2O3@Au, with and without FA modification and the temperature rise profiles of the cells were meas-
ured upon administration of the near-infrared (NIR) laser (808 nm, 6W/cm2, 10min). The recorded tem-
perature profiles of the cells were used for thermal dose calculation. Finally, the level of induced
apoptosis was determined by flow cytometry using an annexin V-fluorescein isothiocyanate/propidium
iodide apoptosis detection kit. The characterization data showed that the Fe2O3@Au NPs are spherical,
with a hydrodynamic size of 33 nm. The data corroborated the successful conjugation of the NPs with
FA. The thermometry results indicated the superior temperature elevation rate of the cells in the pres-
ence of the NPs upon NIR irradiation. Meanwhile, the higher heating rate and the higher thermal dose
were obtained for the cells exposed to FA-targeted Fe2O3@Au rather than the non-targeted nanocom-
plex. Flow cytometry studies revealed that FA-targeted Fe2O3@Au induced higher level of apoptosis
than non-targeted Fe2O3@Au NPs. In conclusion, our findings suggest that the synthesized FA-targeted
Fe2O3@Au NP has high potentials to be considered as an efficient thermosensitizer in the process of
targeted cancer hyperthermia.
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Introduction
In spite of the extensive progress made in the area of cancer
therapy, this disease is still the second-leading cause of mor-
tality worldwide. Recent efforts in this area have focused on
the implementation of nanotechnology to improve the cur-
rent efficiency of cancer diagnosis and therapy. The use of
nanoprobes in association with biomedical imaging has
exhibited great promise in eliminating the current detection
limits of cancer diagnosis [1,2]. On the other hand, chemo-
therapy and radiotherapy, are the major lines of cancer ther-
apy, have been subjected to considerable improvements
through incorporation with nanomaterials [3–7].
Hyperthermia is thought to be another important action
domain in the area of cancer therapy. Cancer hyperthermia
subscribes to the strategy of elevating the temperature of the
tumor, which either induces the immediate killing of cancer
cells if the temperature is high enough (>45 C) or renders
the cancer cells more vulnerable to various therapeutic
modalities for smaller increases in temperature (40–45 C)
[8,9]. Many clinical experiments have reported improved local
tumor control and overall survival in cancer patients by the
implementation of hyperthermia as an adjuvant therapy in
association with chemotherapy or radiotherapy [10,11].
As the hyperthermia energy source propagates throughout
the patient body, the tumor and its collateral healthy tissue
indiscriminately undergo temperature elevation, resulting in
unwanted thermal damages. In nanotechnology-assisted
hyperthermia, however, the tumors are impregnated with the
suitable nanoparticles (NPs) that are able to absorb the
energy of the hyperthermia source and induce localized heat-
ing [12]. This strategy confines the thermal damage to the
tumor site only and keeps the collateral tissues safe [13].
Photothermal therapy (PTT) is considered a beneficial
nanotechnology-assisted hyperthermia approach in which
plasmonic NPs are subjected to laser light in order to absorb
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optical energy and turn it into heat, thus providing a local-
ized hyperthermia strategy. Compared to magnetic hyperther-
mia, the most established nanotechnology-assisted
hyperthermia method, where magnetic NPs generate heat
under an alternating magnetic field, PTT benefits from much
greater heat generation efficiency, making it an attractive
area for research [14–16].
Among all the plasmonic NPs identified to date, gold NPs
(AuNPs) have been introduced as elegant light-responsive
nanomaterials due to their (i) ideal thermophysical properties,
(ii) suitable size for passive accumulation inside the tumor,
(iii) synthetic versatility for fine-tuning size and morphology,
(iv) conjugation with active targeting ligands and (v) inclusion
in biomedical imaging [17–20].
A key perquisite for tumor-specific PTT while preserving
surrounding healthy tissue is to accurately direct AuNPs
towards cancer cells [21–23]. This may be provided by the
exploitation of the active targeting strategy that is based on
the specific identification of targeting ligands (e.g. proteins,
peptides, aptamers and small molecules) conjugated to
AuNPs by cancer cell surface receptors [23]. The vitamin folic
acid (FA) is a necessary ingredient for cell proliferation. Due
to their rapid division rate cancerous cells generally indicate
a higher level of FA receptor expression on their surface than
normal cells in order to meet this need. FA modification of
AuNPs thus endows the NPs with a unique capability to par-
ticularly target cancer cells [24–27].
Besides the use of multimodal imaging modalities, the
real-time guidance of PTT operation is an interesting success
in this area that can further promote the safety and the effi-
ciency of PTT. For example, the unique properties of mag-
netic NPs in the magnetic resonance imaging (MRI) contrast
agent in addition to the light-absorbing properties of AuNPs
have recently led to the development of a multifunctional
magneto-plasmonic nanoplatform, providing the capability of
MRI-guided PTT [28].
This study aims to demonstrate the heat generation cap-
ability of the Iron (III) Oxide (Fe2O3)@Au nanocomplex on illu-
mination by the NIR laser. To this end, the direct temperature
rise of KB cancer cells loaded with the NPs was monitored
during the PTT operation. For illustrating the role of FA tar-
geting on improving the efficiency of PTT, the temperature
rise of cancer cells loaded with FA-modified Fe2O3@Au nano-
complex (Fe2O3@Au-FA) was further evaluated. In addition,
for a better understanding of how the FA-targeting strategy
is efficient in promoting the PTT regimes in the clinic, the
thermometry results were analyzed based on the practical
parameters of the thermal dose. Finally, we determined and
compared the level of cancer cell apoptosis when FA-tar-
geted or non-targeted Fe2O3@Au NP is used in the process of
PTT.
Materials and methods
Material
Iron (II) chloride tetrahydrate (> 99%), iron (III) chloride hexahy-
drate (> 99%), ammonia (32%), hydrochloric acid (HCl), Nitric
acid (HNO3), N-hydroxysuccinimide, dicyclohexylcarbodiimide
and cysteamine were purchased from Merck (Darmstadt,
Germany). Fetal bovin serum (FBS) was purchased from
BioSera Ltd. (Ringmer, United Kingdom). Dubelco’s
Modification of Eagle’s Medium (DMEM) was purchased from
GIBCO (Invitrogen, Germany). Trypsin- ethylene diamine tetra
acetic acid (EDTA), dimethyl sulfoxide (DMSO), penicillin-
streptomycin solution, folic acid and Gold (III) chloride
solution, all were purchased from Sigma-Aldrich Corp.
(St Louis, MO).
Synthesis of Fe2O3@Au core-shell NPs
Fe2O3@Au core-shell NPs were prepared through the oxida-
tion of Ferroferric oxide (Fe3O4) NPs in the aqueous phase
[29]. Briefly, 2.6 g of ferric chloride and 1.0 gr of ferrous chlor-
ide were dissolved in HCl solution (12M) and 12.5ml of
water. The solution was introduced into sodium hydroxide
solution through dropwise addition (125.0ml, 1.5M) with vig-
orous stirring. The generated black precipitate was collected
using a magnet and the supernatant was removed from the
precipitate through decantation. After washing the precipitate
for three times using 50ml of water, HCl solution (250ml,
0.01M) was added to neutralize the anionic charges of the
precipitate; the resulting Fe3O4 NPs were obtained after
washing with water. The freshly prepared Fe3O4 NPs were fur-
ther dissolved in HNO3 (0.01M) and heated under stirring at
100 C for one hour in order to completely oxidize the Fe3O4
NPs to Fe2O3 NPs. The solution was then cooled to room
temperature and washed twice using water, followed by cen-
trifugation at 10,000 RPM for 15min. Fe2O3@Au core-shell NPs
were synthesized through the deposition of Au on Fe2O3 NPs
using the modified Lyon’s iterative hydroxylamine-seeding
procedure [30]. First, Fe2O3 NPs (1.0ml, 1.1mM) was mixed
with sodium citrate (1.0ml, 0.1M) for 10min, followed by
dilution with 20ml H2O. Subsequently, 0.1ml of hydroxyl-
amine hydrochloride (NH2OHHCl) solution and 1.0ml of
Chloroauric acid (HAuCl4) solution were added dropwise
under stirring for a total of 50min. The addition of
NH2OHHCl and HAuCl4 was repeated twice. The solution
changed to garnet after three iterative additions.
Preparation of cysteamine-FA conjugate
First, as shown in Scheme 1(a), the FA N-hydroxysuccinimide
(FA-NHS) active ester was synthesized using a previously
reported method with a minor modification [31,32]. A solu-
tion of anhydrous DMSO and triethylamine (100:1) was stirred
for 10min. Then 0.25 g of FA was added gradually to the
above mixture which was continuously stirred in the dark,
and kept overnight. Later FA was mixed with 0.1 g of dicyclo-
hexylcarbodiamide and 0.1 g of N-hydroxysuccinimide and
was stirred for another 24 h. The by-product, dicyclohexylurea
(DCU), was removed by filtration. DMSO and triethylamine
were evaporated under vacuum. Second, for the preparation
of the cysteamine-FA conjugate, vacuum-dried FA-NHS was
dissolved in the mixture of DMSO and trimethylamine (2:1).
Later, 0.1 g cysteamine was added to the mixture and
stirred overnight. The resulting yellow solid (cysteamine-FA
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conjugate) was obtained by filtration and was washed with
ethyl ether twice.
Surface modification of Fe2O3@Au core-shell NPs with
the cysteamine-FA conjugate
Conjugation of cysteamine-FA on the Fe2O3@Au surface
involved the following method [33]: The dried cysteamine-FA
conjugate was added gradually to the solution of prepared
Fe2O3@Au and the mixture was stirred for four hours at room
temperature to form cysteamine-FA conjugated gold NPs
(Scheme 1(b)). Finally, the prepared cysteamine-FA conju-
gated Fe2O3@Au core-shell NPs were purified by centrifuga-
tion and double re-precipitation from distilled water.
Nanoparticle characterization
The morphology and size distribution of the synthesized NPs
were analyzed by high-resolution transmission electron
microscopy (HR-TEM). The hydrodynamic diameter of the NPs
and their surface charge were measured by dynamic light
scattering (DLS), using the Malvern Zetasizer Nano ZS-90
instrument. The UV-Visible (UV-Vis) absorption spectra of the
NPs dispersed in water were recorded using the Rayleigh UV-
1601 instrument. Fourier transform infra-red (FTIR) spectra
were recorded using the Shimadzu FT-IR 4300 instrument
equipped with pressed potassium bromide pellets at room
temperature. FTIR studies were considered in order to con-
firm the surface functionalization of the nanoconjugate. The
magnetic properties of the nanocomplex were determined
using a vibrating sample magnetometer (VSM; MDK6, Kavir,
Iran).
Cell culture
Cell culture was accomplished in accordance with institu-
tional guidelines with permission received from Ethic
Committee of Iran University of Medical Sciences (IUMS)
under the code of “IR.IUMS.REC 1395.95–04-223–9411338004”.
Our experiments were conducted on the KB cell line, derived
from human mouth epidermal carcinoma. The cells were cul-
tured as a monolayer in the DMEM cell growth media with L-
glutamine and sodium hydroxide supplemented with 10%
FBS, 100 units/ml penicillin and 100 lg/ml streptomycin was
incubated in a humidified atmosphere containing 5% CO2
and 95% air at 37 C.
In vitro experimental procedure
To perform the PTT operation, the KB cells were seeded in a
96-well cell culture plate at a density of 1 104 cells per
well and incubated for 24 h at 37 C in a humidified 5% CO2
atmosphere. The medium solution containing the Fe2O3@Au
and the Fe2O3@Au-FA nanocomplex with different Au con-
centrations of 20, 30 and 40 lg/ml were prepared and added
to the cells. After incubation for another four hours, the cul-
ture medium was removed. The cells were washed twice
with PBS to remove the unloaded NPs and later fresh
medium was added. In order to initiate the PTT operation
from the normal body temperature, the culture plate was
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Scheme 1. (a) Preparation of cysteamine-folic acid conjugate. DCC: dicyclohexylcarbodiimide;NHS: N-hydroxysuccinimide; DMSO: dimethyl sulfoxide; TEA trimethyl-
amine. (b) Surface modification of Fe2O3@Au core-shell nanoparticles with cysteamine-folic acid conjugate.
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placed on a warm surface at a constant temperature of
37 C. After reaching thermal equilibrium between the sur-
face and the culture plate, the cells were irradiated by a
continuous-wave 808 nm laser source (Nanobon Company,
Tehran, Iran) at an intensity of 6W/cm2 for 10min. To
observe the photothermal heating efficiency of Fe2O3@Au
and the Fe2O3@Au-FA nanocomplex, the transient tempera-
ture variations of the cells were monitored with an infrared
(IR) thermal camera (Testo 875–1i, Germany) during the laser
irradiation process.
Thermal dose calculations
The thermal dose was calculated using the corresponding
time-temperature profile of the cells according to the method
developed by Separeto and Dewey, in which the thermal
dose parameter was expressed as CEM 43 C and was calcu-
lated using Equation (1):
CEM 43C ¼
ðt
0
RCEM
43Tð Þdt (1)
where t is the time spent at temperature T and RCEM is the
ratio of exposure times that result in the same cell survival
for a 1 C rise in temperature. For many cell types, RCEM is
generally considered to be 0.5 for temperatures above 43 C
and 0.25 for temperatures below 43 C [34,35].
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay
To test the cytotoxicity of core-shell nanocomplex, the viabil-
ity of KB cells incubated by various concentration of the
nanocomplex was evaluated using MTT tetrazolium assay,
which measures the ability of metabolically active mitochon-
dria in live cells to reduce a colorless tetrazolium compound
to a blue formazan product. To perform this assay, cells were
incubated with various concentrations of nanocomplex (10,
15, 20, 30 and 40 lg/ml). After four hours, the nanocomplex
was removed and cells were washed with PBS. After adding
100ll of FBS-free culture medium, 10 ll MTT dye (at a con-
centration of 5mg/ml) was also added to each well and the
plate was incubated for four hours. Then, MTT-containing
medium was removed and was replaced with DMSO (10ll
per well) to dissolve the formazan crystals which was kept in
the dark at room temperature for 15min. Later the absorb-
ance of the dissolved formazan was read at wavelength of
570 nm by an ELISA reader (DYNEX MRX, USA) using a refer-
ence wavelength of 630 nm. The relative survival of KB cells
was represented as the absorbance of the treated sample/
absorbance of the control group. The optical density (OD) of
dissolved formazan is directly proportional to living cells. In
our experiments, we designed control groups beside the
treated groups and therefore, the cell viability percentage
was calculated using Equation (2):
Cell viability %ð Þ ¼ ðODsample  ODmediumÞðODcontrol  ODmediumÞ  100 (2)
In addition, cytotoxicity tests were similarly repeated for
FA-conjugated nanocomplex, but only at concentration of
20 lg/ml, because this concentration was selected for PTT
experiments.
All experiments were repeated at least three times.
Flow cytometry
The extent of apoptosis was measured through annexin
V-fluorescein isothiocyanate (FITC) apoptosis detection kit as
described in the manufacturer's instructions (eBioscience, San
Diego, CA). After performing PTT experiments on the KB cells
[(laser parameters: 808 nm; 6W/cm2; 10min) and (incubation
conditions: 20 lg/ml for 4 h)], the cells were plated at a dens-
ity of 200,000 cells/well in flat bottom 24-well plates. In brief,
cells were harvested and centrifuged at 300 g for 5min. Then
cells were washed once with PBS) and once with 1binding
buffer. After that, cells were suspended in 1binding buffer
and 5 ll of flurochrome-conjugated annexin V was added to
100 ll of cell suspension and incubated for 15min in dark at
room temperature. Cells were then washed once again with
2ml of binding buffer and was suspended in 200 ll of
1binding buffer. Finally, 5 ll of propidum iodide (PI) stain-
ing solution was added to 200ll cell suspensions and
assessed by flow cytometer (BD FACSCantoII, BD Biosciences,
Franklin Lakes, NJ).
Statistical analysis
Statistical analysis was performed by using the SPSS software
(SPSS, Chicago, IL,version 11). The one-way analysis of vari-
ance (ANOVA) statistical method was used to evaluate the
significance of the experimental data. A value of p< .05 was
considered statistically significant.
Results
Nanoparticle characterization
Figure 1 shows the TEM images of targeted and non-targeted
Fe2O3@Au core–shell NPs in which the Au shell could be
obviously seen on the surface of Fe2O3 NPs. As shown in
Figure 1(a), the magnetic core of the prepared Fe2O3@Au
nanocomplex is 20 nm thick and the gold layer was <3 nm
thick. According to Figure 1(c), the hydrodynamic diameter of
the NPs measured by DLS analysis ranged between 20 and
50 nm, with the highest frequency of 33 nm. Figure 1(d)
shows size distribution of FA functionalized Fe2O3@Au nano-
complex in which hydrodynamic diameter of the NPs ranged
from 30 to 70 nm, with the highest frequency of 46 nm.
The zeta potential of the Fe2O3@Au nanocomplex
was17.9mV, whereas after FA modification, the zeta poten-
tial was changed to22.4mV (Figure 2). UV-Vis spectrometry
was utilized to characterize the synthesized Fe2O3@Au-FA
core-shell NPs (Figure 3). It is clear that the Fe2O3@Au-FA
core-shell NPs display a typical surface plasmon broadened
band at 606 nm, indicative of the formation of Fe2O3@Au-FA
core-shell NPs, whereas the Fe2O3@Au core-shell NPs
display characteristic surface plasmon absorption at 584 nm.
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This red-shift in the position of the maximum absorption indi-
cates that FA has interacted with the Fe2O3@Au core-shell
NPs. In addition, the absorption peak at 304 nm is likely to be
ascribed to the attached FA moieties [36]. As a consequence,
the change in color of the Fe2O3@Au-FA core-shell NPs occur
(Figure 3(c)). The reason behind this alteration in color may
be due to the change in particle size and the alteration in
the refractive index of the medium or in the peripheral
region of the particle [37].
The conjugation of the folate to Fe2O3@Au was verified by
comparing the FTIR spectra of FA and Fe2O3@Au-cysteamine-
FA (Figure 4(a,b)). The band at 1315 cm1 corresponds to the
asymmetric stretching vibration of –NH2 in the folate; the
bands at 1627 and 1677 cm1 relate to the C¼O stretching
in carboxyl acids; the band at 1516 cm1 belongs to the
C¼O bond stretching vibration of the –CONH– group; the
bands between 3000 and 3500 cm1 are due to the O–H
stretching and NH-stretching vibration bands of FA and cyste-
amine [38]. In addition, the absence of the absorption band
at 2100–2300 cm1 is attributed to the characteristic absorp-
tion of -SH of cysteamine by the surface of the AuNPs, sug-
gesting that –SH conjugated with Au on the surface of the
NPs. The bands at 2850–2927 cm1 relate to the asymmetric
and symmetric C-H stretching vibrations of –CH2.
The magnetic properties of Fe2O3@Au nanocomplex and
Fe2O3@Au-FA nanoconjugate were determined using VSM. As
seen in Figure 5, for the synthesized nanocomplexes, no hys-
teresis was detected.
Thermometry results
Temperature monitoring of the cells loaded with NPs during
the PTT operation demonstrated that the Fe2O3@Au NPs pos-
sess a strong light-absorption capability. While KB cells
without NPs showed a negligible temperature rise on laser
irradiation, the presence of Fe2O3@Au NPs inside the cells
appreciably increased the cell temperature. In addition, such
temperature enhancement seems to vary with the concentra-
tion of NPs. Following NIR laser irradiation, KB cells treated
with higher concentrations of NPs reached higher tempera-
tures. The temperature rise profiles of the cells incubated
with different concentrations of Fe2O3@Au and Fe2O3@Au-FA
and irradiated by 808 nm laser are shown in Figures 5 and 6,
respectively. After 10min of laser irradiation, the temperature
of the cells increased from 37 C to 37.7 ± 0.3 C, whereas the
temperature significantly increased to 40.2 ± 0.35 C,
41.2 ± 0.4 C and 42.9 ± 0.3 C for those cells that were
exposed to Fe2O3@Au with different Au concentrations of 20,
30, and 40 mg/ml, respectively (Figure 7). Expressing similar
behavior, the temperature of the cells exposed to Fe2O3@Au-
FA NPs raised to 43.9 ± 0.6 C, 45.9 ± 0.6 C, and 48.5 ± 0.5 C
demonstrated the superior heat-generation capability of
Fe2O3@Au-FA over Fe2O3@Au (Figure 7). It should be noted
that the photothermal conversion inherent capability of
Fe2O3@Au does not vary when functionalized with FA. In the
case of Fe2O3@Au conjugated with FA, intracellular accumula-
tion of the NPs via receptor-mediated endocytosis is
enhanced. Accordingly, KB cells treated with Fe2O3@Au-FA
are expected to have higher intracellular Au content than the
cells treated with non-targeted NPs at the same concentra-
tion. Consequently, upon NIR irradiation, the cells with higher
Au content show a higher temperature elevation than those
cells treated with non-targeted NPs.
Figure 8 shows a comparison between the final tempera-
ture increase of the cells exposed to Fe2O3@Au and
Fe2O3@Au-FA, with different concentrations at the end of
10min of irradiation with the NIR laser. Compared to non-
Figure 1. TEM images(a,b) and DLS of the synthesized core-shell nanoparticles (with and without FA; (c,d)).
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Figure 2. Surface charge distribution of (a) Fe2O3@Au and (b) Fe2O3@Au-FA nanocomplex by zeta potential measurement.
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targeted Fe2O3@Au, the cells exposed to the Fe2O3@Au-FA
indicated a higher temperature increase.
Thermal dose
To estimate the effects of NPs on laser hyperthermia efficacy,
a thermal dose was considered as a practical parameter in
thermotherapy regimes. From the time-temperature profiles
of the cells, a CEM of 43 C was calculated. The amounts of
thermal doses applied to the cells on various treatments,
including the sole action of laser and the combined action of
laser and Fe2O3@Au or Fe2O3@Au-FA, are presented in the
logarithmic scale in Figure 9. As shown in this figure, the
presence of NPs inside the cells dramatically increased the
thermal dose in a concentration-dependent manner. As
expected from the temperature rise profiles of the cells, the
targeted Fe2O3@Au-FA, coupled with laser irradiation,
imparted a significantly higher thermal dose to the cells in
comparison to non-targeted Fe2O3@Au. For example, while
the cells without NPs received a negligible thermal dose of
0.0045± 0.00min, this value was substantially enhanced to
3.79 ± 0.20min for Fe2O3@Au NPs and 265.77 ± 8.27min for
Fe2O3@Au-FA at the same Au concentration of 40 mg/ml.
Cytotoxicity of Fe2O3@Au NPs
It is necessary to evaluate the cytotoxicity of the synthesized
nanomaterials before further biomedical applications.
Therefore, we tested the cytotoxicity of Fe2O3@Au NPs using
MTT assay. The viability of KB cells incubated with different
concentrations of Fe2O3@Au NPs is presented in Figure 10(a).
It was found that Fe2O3@Au NPs induced more than 20% cell
death at concentrations higher than 20 lg/ml. To make a
comparison, the cytotoxicity of FA conjugated Fe2O3@Au NPs
was also examined at the same concentration (20 lg/ml). As
seen in Figure 10(b), there is no significant difference
between the cytotoxicity of Fe2O3@Au-FA and Fe2O3@Au
NPs. As a result, 20 lg/ml was selected as a suitable concen-
tration for further studies and also for PTT of KB cells.
Results of flow cytometry studies
To determine the level of cell death and apoptosis induced in
KB cells following PTT, we evaluated the in vitro effects of
400900140019002400290034003900
%
Tr
an
sm
itt
an
ce
Wavenumbers (cm-1)
Folic acid (FA)
(b)
(a)
Figure 4. Fourier transform infrared (FTIR) spectra of (a) Fe2O3@Au-cysteamine-FA nanoconjugate and (b) FA.
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both targeted and non-targeted NPs in the process of PTT by
flow cytometry. As shown in Figure 11(a), laser or both types
of NPs or laser alone did not highly increase the amount of
cell death compared with the control group. Significant cell
death was obtained when combination of laser and NPs was
tested. In comparison with Fe2O3@Au NP, higher level of cell
death was observed when Fe2O3@Au-FA nanoconjugate was
used in the process of PTT. Moreover, the induction of apop-
tosis was increased when KB cells incubated with FA-targeted
NPs were exposed by laser (Figure 11(b)).
Discussion
The increased temperature rise and the thermal dose due to
the presence of Fe2O3@Au inside the cells upon NIR
irradiation can be attributed to the gold plasmonic shell com-
partment of the NPs that possess the characteristic surface
plasmon bands in the NIR region. Minimal absorption of light
by the tissue in the NIR spectra provides a therapeutic win-
dow that allows for a deeper penetration of light inside the
body. Unlike the spherical gold structures, the surface plas-
mon resonance (SPR) of the nanoshells are tuned to the NIR
region. This is considered a great advantage for Fe2O3@Au
core–shell nanoplatforms over spherical gold nanostructures
as they are capable of converting NIR light to heat, thereby
allowing for the treatment of deep-seated tumors [18]. When
the gold plasmonic shell is subjected to light, the free elec-
trons in the conduction band of AuNPs undergo a collective
coherent oscillation. The amplitude of oscillation becomes
maximum at a specific frequency of incident light; this is
Figure 5. Magnetization curve of Fe2O3@Au nanocomplex and Fe2O3@Au-FA nanoconjugate.
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Figure 6. Temperature rise profile of the KB cancer cells incubated with Fe2O3@Au NPs at different Au concentrations upon administration of NIR laser (808 nm;
6W/cm2; 10min).
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termed as surface plasmon resonance (SPR). The optical
energy obtained by the oscillating electrons turns into heat
and is transferred into the particle lattice via the electro-
n–phonon relaxation. The heat diffuses away from the lattice
via phonon–phonon relaxation, leading to an increased tem-
perature of the surrounding medium [39,40].
Wang et al. [41] evaluated the photothermal efficiency of
the gold magnetic NPs (GMNs) by monitoring the tempera-
ture rise of the GMNs solution under NIR laser irradiation
(808 nm, 1W/cm2, 10min). While water-free NPs showed an
increased temperature of only 4.15 C, the temperature of
GMNs solution (50 mg/ml) increased by 28 C, demonstrating
the efficient NIR absorption potential of gold magnetic core–-
shell structures. This capability was then exploited to damage
cancer cells, where the PTT of the HepG2 hepatocellular car-
cinoma cells in the presence of GMNs (100 mg/ml) caused an
inhibition rate of 82.4%.
As shown in Figure 8, the cells exposed to FA-modified
NPs reached higher temperature increases in comparison to
non-FA modified NPs. Tables 1–3 present comparisons
between the photothermal efficiency of Fe2O3@Au-FA and
Fe2O3@Au NPs at different concentrations. Table 1 shows the
temperature elevation rates for the KB cells loaded with vari-
ous concentrations of Fe2O3@Au-FA and Fe2O3@Au NPs, fol-
lowing 10min of NIR laser irradiation. Table 2 reports the ‘X-
fold’ increase in the temperature elevation rate of the cells
due to the presence of NPs, which is calculated using
Equation (3):
‘X fold’ increase in temperature elevation rate
¼ Temperature elevation rate ðwith nanoparticlesÞ
Temperature elevation rate ðwithout nanoparticlesÞ  1
(3)
Compared to the cells solely treated with the laser, the six-
fold and 15.42-fold increase in the temperature elevation
rate were obtained for the cells treated with laser plus
Fe2O3@Au-FA and Fe2O3@Au NPs (40mg/ml Au concentra-
tion), respectively. Table 3 also presents an increase in the
peak temperature of KB cells treated by the NPs at the end
of 10min of the PTT operation in comparison to the cells
without NPs.
FA is an ingredient required for cell proliferation and can-
cer cells supply this need through overexpression of the FA
receptor on their surface [42,43]. The surface functionalization
of Fe2O3@Au NPs with FA thus provides an active targeting
strategy that directs the NPs towards the cell surface FA
receptor, leading to enhanced uptake and efficient internal-
ization of the NPs via receptor-mediated endocytosis [24,25].
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Figure 7. Temperature rise profile of the KB cancer cells incubated with FA conjugated Fe2O3@Au NPs at different Au concentrations upon administration of NIR
laser (808 nm; 6W/cm2; 10min).
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Figure 8. Final temperature rise of the KB cancer cells incubated with
Fe2O3@Au (black) and Fe2O3@Au-FA NPs (red) at different Au concentration fol-
lowing 10min NIR laser irradiation (808 nm; 6W/cm2).
Figure 9. Thermal doses applied to the KB cancer cells for NIR laser irradiation
(808 nm; 6W/cm2; 10min) alone (concentration ¼0) and for combination of
laser and Fe2O3@Au (black) and Fe2O3@Au-FA NPs (red) at different Au
concentrations.
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For example, Gao et al. [44] evaluated the targeting efficiency
of FA-conjugated silica-coated gold nanorods (FA-SiO2@AuNR)
towards the HepG2 hepatocellular carcinoma cells and
reported a 2.65-fold higher cellular uptake rate for this non-
complex in comparison to the non-FA conjugated nanocom-
plex. In another study, the facility of FA targeting was utilized
for improving the PTT efficiency of the KB cancer cells. After
laser irradiation, the survival of KB cells incubated with 20 lM
AuNRs was reduced from 96.4 to 60.57%, whereas the FA-
conjugated AuNRs at the same concentration further reduced
the cell survival to 44.3% [45]. Accordingly, the higher tem-
perature elevation rate of the KB cells incubated with
Fe2O3@Au-FA NPs in comparison to those cells incubated
with Fe2O3@Au NPs can be related to the enhanced accumu-
lation of the targeted NPs inside the cells, providing more
efficient PTT.
The positive impact of FA targeting on the promotion of
PTT effectiveness would be more prominent if the tempera-
ture profile of the cells were analyzed from the perspective
of the thermal dose. As shown in Figure 9, higher thermal
doses were obtained for Fe2O3@Au-FA NPs in comparison to
Fe2O3@Au NPs. For example, the obtained thermal dose in
the presence of FA conjugated Fe2O3@Au NPs at a concentra-
tion of 20 mg/ml was found to be significantly higher than
the thermal dose obtained with non-targeted Fe2O3@Au NPs
even at a higher Au concentration of 40 mg/ml. Consequently,
the exploitation of the FA targeting facility by enhancing the
cellular uptake of NPs provides a unique opportunity to use
lower NPs concentrations while achieving higher thermal
doses, thereby offering improved laser hyperthermia effi-
ciency. The data presented in Figure 11 also confirms that FA
targeting improve the results of laser hyperthermia.
Conclusion
In this article, we reported the synthesis and characterization
of Fe2O3@Au NPs with and without folate conjugation.
The transient temperature rise of the cells loaded with
Fe2O3@Au core-shell NPs was measured upon the administra-
tion of NIR laser. To normalize the different thermal histories,
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Figure 10. (a) The viability of KB cells incubated with different concentrations of nanoconjugates for 4 h. High level of cytotoxicity is observed for the concentrations
greater than 20 lg/ml. (b) The viability of KB cells incubated with Fe2O3@Au (NPs) and Fe2O3@Au-FA (FA-NPs) for 4 h (concentration: 20 lg/ml).
Table 1. The temperature elevation rates of the KB cancer cells incubated
with different concentrations of Fe2O3@Au NPs and Fe2O3@Au-FA NPs follow-
ing NIR laser irradiation (808 nm; W/cm2; 10min).
Au concentration
Nanoparticles 0 20 mg/ml 30 mg/ml 40 mg/ml
Fe2O3@Au 0.07 C/min 0.32 C/min 0.42 C/min 0.49 C/min
Fe2O3@Au-FA 0.07 C/min 0.69 C/min 0.89 C/min 1.15 C/min
Table 2. The “X-fold” increases in temperature elevation rates of the KB cancer
cells during laser irradiation in the presence of Fe2O3@Au NPs and Fe2O3@Au-
FA NPs at different Au concentrations.
Au concentration
Nanoparticles 20 mg/ml 30 mg/ml 40 mg/ml
Fe2O3@Au 3.57 5 6
Fe2O3@Au-FA 8.85 11.71 15.42
Table 3. The “X-fold” increase in peak temperature of the KB cancer cells incu-
bated with Fe2O3@Au NPs and Fe2O3@Au-FA NPs at different Au concentra-
tions with respect to 0% au concentration at the end of 10min NIR laser
irradiation.
Au concentration
Nanoparticles 20 mg/ml 30 mg/ml 40 mg/ml
Fe2O3@Au 1.06 1.09 1.13
Fe2O3@Au-FA 1.16 1.21 1.28
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the concept of thermal dose, which is relevant to the bio-
logical mechanisms involved in the hyperthermia regimes,
was considered. The conjugation of FA with a high affinity for
KB cancer cells appreciably caused the enhanced accumula-
tion of the NPs inside the cells. Consequently, an obvious
increase in the temperature elevation rate, subsequently
applied thermal dose to the cells and apoptosis was attained
when compared to the non-FA conjugated NPs. Therefore,
the functionalization of NPs with FA provides a potential for
improving laser hyperthermia efficiency through the reduc-
tion of the administrated concentration of NPs while achiev-
ing higher thermal doses and the power density of the laser
used; furthermore, the time needed for a PTT operation could
be potentially reduced.
Disclosure statement
No potential conflict of interest was reported by the authors.
Figure 11. (a) Flow cytometric analysis to determine death modes of KB cells after receiving various treatments. (b) The percentage of necrotic and apoptotic KB
cells after receiving various treatments.
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